KMG Reports Fourth Quarter and Full Year 2018 Financial Results
2018年10月2日 - 9:15AM
KMG (NYSE: KMG), a global provider of specialty chemicals and
performance materials, today announced financial results for the
fourth fiscal quarter and fiscal year ended July 31, 2018.
2018 Fourth Quarter Financial Highlights
- Sales grew to a record $122.4 million, an increase of 27%
compared to the same quarter last year.
- GAAP diluted earnings per share was $1.13, up 163% compared to
$0.43 per diluted share in the fourth quarter of fiscal 2017.
- Adjusted diluted earnings per share1 increased to a record
$1.26 compared to $0.69 per share reported in the fourth quarter of
fiscal 2017.
- GAAP net income rose 237% to $18.0 million compared to $5.3
million in last year’s fourth quarter.
- Adjusted EBITDA2 increased to $31.1 million, from $20.6 million
in the fourth quarter of fiscal 2017.
2018 Fiscal Year Financial Highlights
- Sales increased 40% year-over-year to a record $465.6
million.
- GAAP diluted earnings per share was a record $4.29, up from
$1.92 in fiscal 2017.
- Adjusted diluted earnings per share was a record $4.33, up 91%
from the prior year.
- GAAP net income rose 174% from the prior year to a record $64.8
million.
- Adjusted EBITDA grew to a record $119.5 million, an increase of
99% from the prior year’s $60.2 million.
Recent Merger Announcement
On August 15, 2018, Cabot Microelectronics Corporation and KMG
Chemicals, Inc. announced a definitive agreement under which Cabot
Microelectronics will acquire KMG Chemicals in a cash and stock
transaction with a total enterprise value of approximately $1.6
billion. Under the terms of the agreement, KMG shareholders will be
entitled to receive, per KMG share, $55.65 in cash and 0.2000 of a
share of Cabot Microelectronics common stock.
Due to the pending transaction with Cabot Microelectronics, KMG
is not hosting a conference call in conjunction with its fourth
quarter and full year 2018 earnings release and does not expect to
do so for future quarters. Completion of the transaction is subject
to approval by KMG’s shareholders and other customary closing
conditions. The transaction is expected to close by the end of the
current calendar year.
“Fiscal 2018 was a year of progress, growth and continued strong
performance for KMG,” said Chris Fraser, KMG chairman and CEO. “We
again achieved record financial results, with fiscal 2018 sales
exceeding the top end of our upwardly revised guidance range and
fiscal 2018 adjusted EBITDA at the high end of our forecast. We
also achieved record earnings per share of $4.29 on a GAAP basis.
Throughout the year, we further strengthened our diverse and
market-leading businesses and continued to enhance our efficiency
across our global operations.”
Mr. Fraser concluded, “Over the past five years, KMG’s adjusted
EBITDA and adjusted earnings per share have increased approximately
fourfold, a period of sustained growth and progress that culminated
in an outstanding fiscal 2018 year. I would like to thank our
exceptional employees whose dedication, passion and teamwork have
driven our growth and success for more than two decades. On behalf
of our entire organization, I sincerely thank our investors for
placing their confidence and trust in KMG.”
Consolidated results
Fourth
Quarter Dollars in thousands, except EPS |
Fiscal 2018 |
|
Fiscal 2017 |
|
As Reported |
Adjusted |
As Reported |
Adjusted |
|
(GAAP) |
(non-GAAP)3 |
(GAAP) |
(non-GAAP)4 |
Net sales |
$122,394 |
|
$122,394 |
|
$96,260 |
|
$96,260 |
|
Operating income |
|
22,362 |
|
|
26,870 |
|
|
10,245 |
|
|
14,628 |
|
Operating margin |
|
18.3% |
|
|
22.0% |
|
|
10.6% |
|
|
15.2% |
|
Net income |
|
18,009 |
|
|
20,199 |
|
|
5,338 |
|
|
8,535 |
|
Diluted earnings per
share |
$1.13 |
|
$1.26 |
|
$ 0.43 |
|
$0.69 |
|
Fiscal Year
ended July 31Dollars in thousands, except EPS |
Fiscal 2018 |
|
Fiscal 2017 |
|
As Reported |
Adjusted |
As Reported |
Adjusted |
|
(GAAP) |
(non-GAAP)5 |
(GAAP) |
(non-GAAP)6 |
Net sales |
$465,556 |
|
$465,556 |
|
$333,442 |
|
$333,442 |
|
Operating income |
|
88,125 |
|
|
102,617 |
|
|
37,333 |
|
|
43,300 |
|
Operating margin |
|
18.9% |
|
|
22.0% |
|
|
11.2% |
|
|
13.0% |
|
Net income |
|
64,841 |
|
|
65,404 |
|
|
23,633 |
|
|
27,859 |
|
Diluted earnings per
share |
$ 4.29 |
|
$4.33 |
|
$1.92 |
|
$ 2.27 |
|
Business segment results
Electronic
Chemicals |
Fourth Quarter |
|
Fourth Quarter |
|
Full Year |
|
Full Year |
Dollars in
thousands |
Fiscal 2018 |
|
Fiscal 2017 |
Fiscal 2018 |
|
Fiscal 2017 |
|
As Reported |
|
As Reported |
As Reported |
|
As Reported |
|
(GAAP) |
|
(GAAP) |
(GAAP) |
|
(GAAP) |
Net sales |
$79,622 |
|
$71,792 |
302,023 |
|
$276,621 |
Operating income |
11,678 |
|
9,132 |
46,554 |
|
35,285 |
Operating margin |
14.7% |
|
12.7% |
15.4% |
|
12.8% |
For the fourth fiscal quarter, the Electronic Chemicals segment
reported:
- Sales of $79.6 million, up 10.9% from the fourth quarter of
fiscal 2017. Product volume growth primarily drove the sales
increase.
- Operating income of $11.7 million, up 27.8% from $9.1 million
in the same period of fiscal 2017. Operating income increased
primarily due to product volume growth and operating efficiencies.
Operating margin improved to 14.7% compared to 12.7% in the
prior-year period.
- Adjusted EBITDA7 of $14.5 million compared to $12.9 million
last year.
For the fiscal 2018 year, the Electronic Chemicals segment
reported:
- Sales of $302.0 million, an increase of 9.2% compared to the
prior year. Product volume growth was the primary driver of the
sales increase.
- Operating income of $46.6 million, up 31.9% from $35.3 million
in the prior year. Operating income increased due to product volume
growth, a favorable product mix and operating efficiencies.
Operating margin increased to 15.4% from 12.8% in the prior
year.
- Adjusted EBITDA8 of $57.2 million compared to $48.8 million in
fiscal 2017.
Performance MaterialsThe Performance Materials
segment consists of the pipeline performance business and the wood
treating chemicals business.
PerformanceMaterials |
Fourth Quarter |
|
Fourth Quarter |
|
Full Year |
|
Full Year |
Dollars in
thousands |
Fiscal 2018 |
|
Fiscal 2017 |
Fiscal 2018 |
|
Fiscal 2017 |
|
As Reported |
|
As Reported |
As Reported |
|
As Reported |
|
(GAAP) |
|
(GAAP) |
(GAAP) |
|
(GAAP) |
Net sales |
$42,772 |
|
$24,468 |
$163,533 |
|
$56,821 |
Operating income |
14,557 |
|
2,877 |
54,991 |
|
13,804 |
Operating margin |
34.0% |
|
11.8% |
33.6% |
|
24.3% |
For the fourth fiscal quarter, the Performance Materials segment
reported:
- Sales of $42.8 million, up 75% from $24.5 million in the same
period a year ago. Sales growth reflected a full quarter of
contribution from Flowchem as compared to a partial quarter in Q4
2017, as well as product volume growth in the pipeline performance
and wood treating chemicals businesses.
- Operating income of $14.6 million, or 34.0% of sales, compared
to $2.9 million, or 11.8% of sales, last year. The increase in
operating income was due to a full quarter of contribution from
Flowchem as compared to a partial quarter in Q4 2017, as well as
product volume growth in the pipeline performance and wood treating
chemicals businesses. Operating income in the fourth quarter of
fiscal 2017 was dampened due to the step-up in basis for acquired
Flowchem inventories totaling $3.7 million, as well as a $2.5
million increase in depreciation and amortization related to the
acquisitions of Sealweld and Flowchem.
- Adjusted EBITDA9 of $18.8 million compared to $10.1 million
last year.
For the fiscal 2018 year, the Performance Materials segment
reported:
- Sales of $163.5 million, up 188% from the prior year. The sales
increase was driven by full-year contributions from Sealweld and
Flowchem, as well as product volume growth in the pipeline
performance and wood treating chemicals businesses.
- Operating income of $55.0 million, or 33.6% of sales, compared
to $13.8 million, or 24.3% of sales, last year. Operating income
improved due to higher sales and product volume growth in the
pipeline performance and wood treating chemicals businesses.
Operating income in fiscal 2017 was unfavorably impacted by a $3.7
million purchase price adjustment to acquired Flowchem inventories
and a $2.7 million increase in depreciation and amortization.
- Adjusted EBITDA10 of $71.8 million compared to $22.3 million
last year.
About KMGKMG Chemicals, Inc., through its
subsidiaries, produces and distributes specialty chemicals and
performance materials for the semiconductor, industrial wood
preservation, and pipeline and energy markets. For more
information, visit the Company's website at
http://kmgchemicals.com.
The information in this news release includes certain
forward-looking statements that are based upon assumptions that in
the future may prove not to have been accurate and are subject to
significant risks and uncertainties, including statements as to the
future performance of the company. Although the company believes
that the expectations reflected in its forward-looking statements
are reasonable, it can give no assurance that such expectations or
any of its forward-looking statements will prove to be correct.
Factors that could cause results to differ include, but are not
limited to, successful performance of internal plans, product
development acceptance, the impact of competitive services and
pricing and general economic risks and uncertainties.
_____________________________________________________________________1
Non-U.S. GAAP measure. See Table 2 for reconciliation.2 Non-U.S.
GAAP measure. See Tables 1 and 1A for reconciliation.3 Non-U.S.
GAAP measure. See Tables 2 and 2A for reconciliation.4 Non-U.S.
GAAP measure. See Tables 2 and 2A for reconciliation.5 Non-U.S.
GAAP measure. See Tables 2 and 2A for reconciliation.6 Non-U.S.
GAAP measure. See Tables 2 and 2A for reconciliation.7 Non-U.S.
GAAP measure. See Tables 1 and 1A for reconciliation.8 Non-U.S.
GAAP measure. See Tables 1 and 1A for reconciliation.9 Non-U.S.
GAAP measure. See Tables 1 and 1A for reconciliation.10 Non-U.S.
GAAP measure. See Tables 1 and 1A for reconciliation.
|
|
KMG CHEMICALS, INC. AND
SUBSIDIARIESCONSOLIDATED STATEMENTS OF
INCOME(In thousands, except per share
amounts) |
|
|
Three Months Ended |
|
Year Ended |
|
July 31, |
|
July 31, |
|
2018 |
|
2017 |
|
2018 |
|
2017 |
Net sales |
$122,394 |
|
|
$96,260 |
|
|
$465,556 |
|
|
$333,442 |
|
Cost of sales |
|
70,959 |
|
|
|
59,518 |
|
|
|
267,895 |
|
|
|
203,304 |
|
Gross
profit |
|
51,435 |
|
|
|
36,742 |
|
|
|
197,661 |
|
|
|
130,138 |
|
|
|
|
|
|
|
|
|
Distribution
expenses |
|
9,247 |
|
|
|
9,989 |
|
|
|
36,439 |
|
|
|
38,318 |
|
Selling, general and
administrative expenses |
|
15,961 |
|
|
|
12,279 |
|
|
|
57,900 |
|
|
|
50,188 |
|
Amortization of
intangible assets |
|
3,860 |
|
|
|
4,279 |
|
|
|
15,123 |
|
|
|
4,279 |
|
Restructuring
charges |
|
5 |
|
|
|
(50 |
) |
|
|
74 |
|
|
|
20 |
|
Operating
income |
|
22,362 |
|
|
|
10,245 |
|
|
|
88,125 |
|
|
|
37,333 |
|
Other (expense)
income |
|
|
|
|
|
|
|
Interest
expense, net |
|
(4,196 |
) |
|
|
(4,167 |
) |
|
|
(21,529 |
) |
|
|
(4,817 |
) |
Loss on
the extinguishment of debt |
|
(342 |
) |
|
|
(353 |
) |
|
|
(6,710 |
) |
|
|
(353 |
) |
Derivative fair value gain |
|
338 |
|
|
− |
|
|
5,576 |
|
|
− |
Other,
net |
|
(86 |
) |
|
|
190 |
|
|
|
(1,063 |
) |
|
|
279 |
|
Total
other (expense) income, net |
|
(4,286 |
) |
|
|
(4,330 |
) |
|
|
(23,726 |
) |
|
|
(4,891 |
) |
|
|
|
|
|
|
|
|
Income before income
taxes |
|
18,076 |
|
|
|
5,915 |
|
|
|
64,399 |
|
|
|
32,442 |
|
Provision
for income taxes |
|
(67 |
) |
|
|
(577 |
) |
|
|
442 |
|
|
|
(8,809 |
) |
Net income |
|
18,009 |
|
|
$5,338 |
|
|
|
64,841 |
|
|
$23,633 |
|
Earnings per
share: |
|
|
|
|
|
|
|
Net
income per common share basic |
$1.16 |
|
|
$0.45 |
|
|
$4.41 |
|
|
$1.99 |
|
Net
income per common share diluted |
$1.13 |
|
|
$0.43 |
|
|
$4.29 |
|
|
$1.92 |
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding: |
|
|
|
|
|
|
|
Basic |
|
15,507 |
|
|
|
11,890 |
|
|
|
14,708 |
|
|
|
11,885 |
|
Diluted |
|
15,994 |
|
|
|
12,436 |
|
|
|
15,111 |
|
|
|
12,286 |
|
|
|
KMG CHEMICALS, INC. AND
SUBSIDIARIESCONSOLIDATED BALANCE SHEETS
(In thousands, except for share and per share
amounts) |
|
|
July 31, |
July 31, |
|
2018 |
2017 |
|
|
|
Assets |
|
|
Current assets |
|
|
Cash and cash
equivalents |
$24,436 |
|
$20,708 |
|
Accounts
receivable |
|
|
Trade,
net of allowances of $219 at July 31, 2018 and $263 at
July 31, 2017 |
|
61,895 |
|
|
51,168 |
|
Other |
|
9,943 |
|
|
6,168 |
|
Inventories, net |
|
54,218 |
|
|
46,482 |
|
Prepaid expenses and
other |
|
4,807 |
|
|
8,617 |
|
Total current
assets |
|
155,299 |
|
|
133,143 |
|
|
|
|
Property, plant and
equipment, net |
|
117,101 |
|
|
105,435 |
|
Goodwill |
|
233,204 |
|
|
224,391 |
|
Intangible assets,
net |
|
300,457 |
|
|
320,401 |
|
Other assets, net |
|
12,373 |
|
|
9,061 |
|
Total assets |
|
818,434 |
|
$792,431 |
|
|
|
|
Liabilities
& stockholders’ equity |
|
|
Current
liabilities |
|
|
Accounts payable |
$39,005 |
|
$29,570 |
|
Accrued
liabilities |
|
12,524 |
|
|
12,456 |
|
Employee incentive
accrual |
|
7,726 |
|
|
7,713 |
|
Current portion of
long-term debt |
− |
|
3,167 |
|
Total current
liabilities |
|
59,255 |
|
|
52,906 |
|
|
|
|
Long-term debt |
|
306,119 |
|
|
523,102 |
|
Deferred tax
liabilities |
|
32,129 |
|
|
37,944 |
|
Other long-term
liabilities |
|
4,864 |
|
|
4,763 |
|
Total liabilities |
|
402,367 |
|
|
618,715 |
|
|
|
|
Commitments and
contingencies |
|
|
|
|
|
Stockholders’
equity |
|
|
Preferred stock, $.01
par value, 10,000,000 shares authorized, none issued |
|
− |
|
|
− |
|
Common stock, $.01 par
value, 40,000,000 shares authorized, 15,509,733 shares |
|
|
|
|
|
|
issued
and outstanding at July 31, 2018 and 11,889,649 shares issued
and |
|
|
|
|
|
|
outstanding at July 31, 2017 |
|
155 |
|
|
119 |
|
Additional paid-in
capital |
|
222,371 |
|
|
42,535 |
|
Accumulated other
comprehensive loss |
|
(10,321) |
|
|
(9,712) |
|
Retained earnings |
|
203,862 |
|
|
140,774 |
|
Total stockholders’
equity |
|
416,067 |
|
|
173,716 |
|
Total liabilities and
stockholders’ equity |
|
818,434 |
|
$792,431 |
|
|
|
KMG CHEMICALS, INC. AND
SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH
FLOWS(In thousands) |
|
|
Year Ended |
|
July 31, |
|
2018 |
|
2017 |
Cash flows from
operating activities |
|
|
|
|
|
|
|
Net
income |
$ |
64,841 |
|
|
$ |
23,633 |
|
Adjustments to reconcile net income to net cash provided by
operating activities |
|
|
|
|
|
|
|
Depreciation and amortization |
|
29,948 |
|
|
|
16,964 |
|
Loss on
extinguishment of debt |
|
6,710 |
|
|
|
353 |
|
Amortization of loan costs included in interest expense |
|
1,421 |
|
|
|
401 |
|
Stock-based compensation expense |
|
7,964 |
|
|
|
6,259 |
|
Deferred
income tax (benefit)/expense |
|
(5,517 |
) |
|
|
(1,090 |
) |
Other |
|
371 |
|
|
|
(1,028 |
) |
Derivative fair value gain |
|
(5,576 |
) |
|
|
− |
|
Debt
repricing transaction costs |
|
607 |
|
|
|
− |
|
Changes
in operating assets and liabilities |
|
|
|
|
|
|
|
Accounts
receivable — trade |
|
(11,039 |
) |
|
|
(3,146 |
) |
Accounts
receivable — other |
|
(2,221 |
) |
|
|
254 |
|
Inventories |
|
(8,206 |
) |
|
|
2,870 |
|
Other
current and noncurrent assets |
|
(566 |
) |
|
|
(1,500 |
) |
Accounts
payable |
|
9,904 |
|
|
|
(1,096 |
) |
Accrued
liabilities and other |
|
(666 |
) |
|
|
2,049 |
|
Net cash
provided by operating activities |
|
87,975 |
|
|
|
44,923 |
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities |
|
|
|
|
|
|
|
Additions
to property, plant and equipment |
|
(23,654 |
) |
|
|
(13,074 |
) |
Purchase
of Sealweld, net of cash acquired |
|
(585 |
) |
|
|
(16,599 |
) |
Purchase
of Flowchem, net of cash acquired |
|
− |
|
|
|
(495,000 |
) |
Other
investing activities |
|
(988 |
) |
|
|
(753 |
) |
Proceeds
from insurance claim |
|
50 |
|
|
|
1,251 |
|
Net cash
used in investing activities |
|
(25,177 |
) |
|
|
(524,175 |
) |
|
|
|
|
|
|
|
|
Cash flows from
financing activities |
|
|
|
|
|
|
|
Proceeds
from sale of common stock, net of issuance costs |
|
175,637 |
|
|
|
− |
|
Principal
payments on borrowings of term loan |
|
(228,000 |
) |
|
|
(10,000 |
) |
Debt
repricing transaction costs |
|
(607 |
) |
|
|
− |
|
Proceeds
from term loan |
|
− |
|
|
|
550,000 |
|
Borrowings under credit facility |
|
− |
|
|
|
17,000 |
|
Deferred
financing costs |
|
− |
|
|
|
(15,323 |
) |
Net
payments under credit facility |
|
− |
|
|
|
(52,800 |
) |
Cash
payments related to tax withholdings from stock-based awards |
|
(3,729 |
) |
|
|
(277 |
) |
Payment
of dividends |
|
(1,753 |
) |
|
|
(1,423 |
) |
Other
financing activities |
|
32 |
|
|
|
− |
|
Net cash
(used in)/provided by financing activities |
|
(58,420 |
) |
|
|
487,177 |
|
|
|
|
|
|
|
|
|
Effect of exchange rate
changes on cash |
|
(650 |
) |
|
|
(645 |
) |
Net increase in cash,
cash equivalents and restricted cash |
|
3,728 |
|
|
|
7,280 |
|
Cash, cash equivalents
and restricted cash at beginning of period |
|
20,708 |
|
|
|
13,428 |
|
Cash, cash equivalents
and restricted cash at end of period |
$ |
24,436 |
|
|
$ |
20,708 |
|
|
Reconciliation of GAAP financial measures to non-GAAP
financial measuresKMG provides non-GAAP financial
information to complement reported GAAP results. KMG believes that
analysis of our financial performance would be enhanced by an
understanding of the factors underlying that performance and our
judgments about the likelihood that particular factors will repeat.
We define adjusted EBITDA as earnings from operations before
interest, taxes, depreciation, amortization, acquisition and
integration expenses, restructuring and realignment charges and
other relevant items.
KMG intends to continue to provide certain non-GAAP financial
information and the appropriate reconciliation to GAAP in its
financial results. As required by SEC rules, the tables below
present a reconciliation of our presented non-GAAP measures to the
most directly comparable GAAP measures. These non-GAAP measures
should be viewed as a supplement to, and not a substitute for, U.S.
GAAP measures of performance.
Table 1RECONCILIATION OF CONSOLIDATED
GAAP NET INCOME TO CONSOLIDATED ADJUSTED EBITDA
(in thousands) |
Fourth QuarterFiscal
2018 |
Fourth QuarterFiscal
2017 |
Consolidated GAAP net
income |
$18,009 |
|
$5,338 |
|
Add back: |
|
|
Interest
expense, net |
|
4,196 |
|
|
4,167 |
|
Loss on
the extinguishment of debt |
|
342 |
|
|
353 |
|
Provision
for income taxes |
|
67 |
|
|
577 |
|
Depreciation & amortization* |
|
7,590 |
|
|
6,100 |
|
Acquisition & integration expenses |
|
1,266 |
|
|
− |
|
Derivative fair value gain |
|
(338) |
|
|
− |
|
Corporate
relocation expense |
|
− |
|
|
405 |
|
Restructuring charges, excluding accelerated depreciation |
|
5 |
|
|
1 |
|
Effect of
purchase price accounting on acquired inventories valuation** |
|
− |
|
|
(50) |
|
Purchase
price adjustment to inventories |
|
− |
|
|
3,674 |
|
Consolidated adjusted
EBITDA |
$31,137 |
|
$20,565 |
|
|
* Includes
depreciation related to restructuring and realignment included in
non-cash restructuring and realignment charges on the statement of
cash flows.** Higher costs of goods sold for our performance
materials segment related to the fair value adjustment in purchase
accounting for acquired inventories. |
(in thousands) |
Year EndedJuly 31,
2018 |
|
Year EndedJuly 31,
2017 |
|
Consolidated GAAP net
income |
$64,841 |
|
|
$23,633 |
|
Add back (deduct): |
|
|
|
|
Interest
expense, net |
|
21,529 |
|
|
|
4,817 |
|
Income
taxes |
|
(442) |
|
|
|
8,809 |
|
Depreciation & amortization* |
|
29,948 |
|
|
|
16,964 |
|
Loss on
the extinguishment of debt |
|
6,710 |
|
|
|
353 |
|
Derivative fair value gain |
|
(5,576) |
|
|
|
— |
|
Debt
repricing transaction costs |
|
607 |
|
|
|
— |
|
Acquisition & integration expenses |
|
1,843 |
|
|
|
1,550 |
|
Corporate
relocation expense |
|
— |
|
|
|
370 |
|
Restructuring & realignment charges, excluding accelerated
depreciation |
|
74 |
|
|
|
20 |
|
Effect of
purchase price accounting on acquiredinventories valuation** |
|
— |
|
|
|
3,674 |
|
Consolidated adjusted
EBITDA |
$119,534 |
|
|
$60,190 |
|
|
* Includes
depreciation related to restructuring and realignment included in
non-cash restructuring and realignment charges on the statement of
cash flows.** Higher costs of goods sold for our performance
materials segment related to the fair value adjustment in purchase
accounting for acquired inventories. |
|
Table 1ARECONCILIATION OF OPERATING
INCOME TO ADJUSTED EBITDANote that we do not allocate
certain financial statement line items below operating income to
our segments; as such, the reconciliations below only reflect the
reconciliation of our operating income by segment to our non-GAAP
measures.
Fourth Quarter
Fiscal 2018 |
Electronic |
|
Performance |
|
|
|
(in thousands) |
Chemicals |
|
Materials |
|
|
Corporate |
|
|
Total |
|
Operating
Income (Loss) |
$11,678 |
$14,557 |
|
($3,873) |
|
$22,362 |
|
Other income (expense),
net |
|
61 |
|
(72) |
|
|
(75) |
|
|
(86) |
|
Depreciation and
amortization |
|
2,727 |
|
4,325 |
|
|
538 |
|
|
7,590 |
|
Acquisition &
integration expenses |
− |
|
38 |
|
|
1,228 |
|
|
1,266 |
|
Restructuring
charges |
|
5 |
|
− |
|
|
− |
|
|
5 |
|
Adjusted
EBITDA |
|
14,471 |
|
18,848 |
|
|
(2,182) |
|
|
31,137 |
|
Corporate
allocation |
|
3,201 |
|
2,458 |
|
|
(5,659) |
|
|
− |
|
Adjusted EBITDA
excl. corporate allocation |
$17,672 |
$21,306 |
|
($7,841) |
|
$31,137 |
|
|
Year Ended July
31, 2018 |
|
Electronic |
|
|
Performance |
|
|
|
|
|
|
(in thousands) |
|
Chemicals |
|
|
Materials |
|
|
Corporate |
|
|
Total |
|
Operating
Income (Loss) |
$46,554 |
|
$54,991 |
|
|
($13,420) |
|
|
$88,125 |
|
Other income (expense),
net |
|
(555) |
|
|
(112) |
|
|
(396) |
|
|
(1,063) |
|
Depreciation and
amortization |
|
11,145 |
|
|
16,743 |
|
|
2,060 |
|
|
29,948 |
|
Acquisition &
integration expenses |
|
− |
|
|
163 |
|
|
1,680 |
|
|
1,843 |
|
Restructuring
charges |
|
74 |
|
|
− |
|
|
− |
|
|
74 |
|
Debt repricing
transaction costs |
|
− |
|
|
− |
|
|
607 |
|
|
607 |
|
Adjusted
EBITDA |
|
57,218 |
|
|
71,785 |
|
|
(9,469) |
|
|
119,534 |
|
Corporate
allocation |
|
12,304 |
|
|
8,351 |
|
|
(20,655) |
|
|
− |
|
Adjusted EBITDA
excl. corporate allocation |
$69,522 |
|
$80,136 |
|
|
($30,124) |
|
|
$119,534 |
|
|
Fourth Quarter
Fiscal 2017 |
|
Electronic |
|
Performance |
|
|
|
(in thousands) |
|
Chemicals |
|
Materials |
|
|
Corporate |
|
|
Total |
|
Operating
Income (Loss) |
$9,234 |
$2,877 |
|
($1,866) |
|
$10,245 |
|
Other income (expense),
net |
|
397 |
|
(101) |
|
|
(106) |
|
|
190 |
|
Depreciation and
amortization |
|
3,282 |
|
2,821 |
|
|
(3) |
|
|
6,100 |
|
Acquisition &
integration expenses |
|
12 |
|
819 |
|
|
(426) |
|
|
405 |
|
Effect of purchase
price accounting on acquired inventories valuation |
|
— |
|
3,674 |
|
|
— |
|
|
3,674 |
|
Restructuring
charges* |
|
— |
|
— |
|
|
(50) |
|
|
(50) |
|
Corporate relocation
expense |
|
— |
|
— |
|
|
1 |
|
|
1 |
|
Adjusted
EBITDA |
|
12,924 |
|
10,090 |
|
|
(2,449) |
|
|
20,565 |
|
Corporate
allocation |
|
3,896 |
|
1,006 |
|
|
(4,902) |
|
|
— |
|
Adjusted EBITDA
excl. corporate allocation |
$16,820 |
$11,096 |
|
($7,351) |
|
$20,565 |
|
*Excludes
depreciation |
Year Ended July
31, 2017 |
Electronic |
|
Performance |
|
|
|
(in thousands) |
Chemicals |
|
Materials |
|
|
Corporate |
|
|
Total |
Operating
Income (Loss) |
$35,317 |
$13,804 |
|
($11,788) |
|
$37,333 |
Other income (expense),
net |
659 |
|
(167) |
|
|
(215) |
|
|
277 |
Depreciation and
amortization |
12,772 |
|
4,192 |
|
|
— |
|
|
16,964 |
Acquisition & integration expenses |
20 |
|
819 |
|
|
712 |
|
|
1,550 |
Effect of
purchase price accounting on acquired inventories valuation |
— |
|
3,674 |
|
|
— |
|
|
3,674 |
Restructuring charges |
— |
|
— |
|
|
20 |
|
|
20 |
Corporate relocation
expense |
— |
|
— |
|
|
370 |
|
|
370 |
Adjusted
EBITDA |
48,768 |
|
22,322 |
|
|
(10,900) |
|
|
60,190 |
Corporate
allocation |
12,894 |
|
3,282 |
|
|
(16,176) |
|
|
— |
Adjusted EBITDA
excl. corporate allocation |
$61,662 |
$25,604 |
|
($27,076) |
|
$60,190 |
* Excludes
depreciation |
|
Table 2RECONCILIATION OF NET INCOME TO
ADJUSTED NET INCOME AND ADJUSTED DILUTED EARNINGS PER
SHARE
(in thousands) |
Three Months Ended |
|
July 31, |
|
2018 |
|
2017 |
Net income |
$18,009 |
|
|
$5,338 |
|
Items impacting pre-tax
income: |
|
|
|
Amortization of Flowchem intangible assets |
|
3,237 |
|
|
|
— |
|
Loss on
the extinguishment of debt |
|
342 |
|
|
|
353 |
|
Acquisition & integration expenses |
|
1,266 |
|
|
|
405 |
|
Amortization of debt discounts and financing costs |
|
298 |
|
|
|
— |
|
Restructuring & realignment charges |
|
5 |
|
|
|
(50) |
|
Derivative fair value gain |
|
(338) |
|
|
|
— |
|
Impact of
the Tax Cuts and Jobs Act |
|
(1,321) |
|
|
|
— |
|
Corporate
relocation expense |
|
— |
|
|
|
1 |
|
Effect of
purchase price accounting on acquired inventories valuation* |
|
— |
|
|
|
3,674 |
|
Provision
for income taxes** |
|
(1,299) |
|
|
|
(1,186) |
|
Adjusted net
income |
$20,199 |
|
|
$8,535 |
|
Adjusted diluted
earnings per share |
$1.26 |
|
|
$ 0.69 |
|
Weighted average
diluted shares outstanding |
|
15,994 |
|
|
|
12,436 |
|
|
* Higher
costs of goods sold for our performance materials segment related
to the fair value adjustment in purchase accounting for acquired
inventories. Only 73% of the purchase price adjustment is
deductible for income taxes and has therefore been included in the
calculation of the tax-effect of the items impacting pre-tax
income. ** For fiscal year 2018, represents the aggregate
tax-effect assuming a 27% tax rate of the items impacting pre-tax
income, which is our estimated U.S. statutory federal tax rate for
fiscal year 2018 following the enactment of the Tax Cut and Jobs
Act of 2017 in December 2017. For the fiscal year ended 2017,
represents the aggregate tax-effect of assuming a 35% tax rate of
items impacting pre-tax income. |
(in thousands) |
Year Ended |
|
July 31, |
|
2018 |
|
2017 |
Net income |
$64,841 |
|
|
$23,633 |
|
Items impacting pre-tax
income: |
|
|
|
Amortization of Flowchem intangible assets |
|
12,575 |
|
|
|
— |
|
Loss on
extinguishment of debt |
|
6,710 |
|
|
|
353 |
|
Acquisition & integration expenses |
|
1,843 |
|
|
|
1,550 |
|
Amortization of debt discounts and financing costs |
|
1,421 |
|
|
|
— |
|
Debt
repricing transaction costs |
|
607 |
|
|
|
— |
|
Restructuring & realignment charges |
|
74 |
|
|
|
20 |
|
Derivative fair value gain |
|
(5,576) |
|
|
|
— |
|
Impact of
the Tax Cuts and Jobs Act |
|
(12,326) |
|
|
|
— |
|
Corporate
relocation expense |
|
— |
|
|
|
370 |
|
Effect of
purchase price accounting on acquired inventories valuation* |
|
— |
|
|
|
3,674 |
|
Income
taxes** |
|
(4,765) |
|
|
|
(1,741) |
|
Adjusted net
income |
$65,404 |
|
|
$27,859 |
|
Adjusted diluted
earnings per share |
$4.33 |
|
|
$2.27 |
|
Weighted average
diluted shares outstanding |
|
15,111 |
|
|
|
12,286 |
|
|
* Higher
costs of goods sold for our performance materials segment related
to the fair value adjustment in purchase accounting for acquired
inventories. Only 73% of the purchase price adjustment is
deductible for income taxes and has therefore been included in the
calculation of the tax-effect of the items impacting pre-tax
income. ** For fiscal year 2018, represents the aggregate
tax-effect assuming a 27% tax rate of the items impacting pre-tax
income, which is our estimated U.S. statutory federal tax rate for
fiscal year 2018 following the enactment of the Tax Cut and Jobs
Act of 2017 in December 2017. For the fiscal year ended 2017,
represents the aggregate tax-effect of assuming a 35% tax rate of
items impacting pre-tax income. |
|
Table 2ARECONCILIATION OF GAAP
FINANCIAL MEASURES TO NON-GAAP FINANCIAL MEASURES
Fourth Quarter
Fiscal 2018 |
KMG Chemicals, Inc. |
Dollars in thousands,
except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP measure |
$22,362 |
|
18.3% |
|
|
$18,009 |
|
|
$1.13 |
Amortization of
Flowchem intangible assets |
|
3,237 |
|
2.6% |
|
|
|
2,363 |
|
|
0.15 |
Acquisition &
integration expenses |
|
1,266 |
|
1.0% |
|
|
|
924 |
|
|
0.05 |
Restructuring &
realignment charges |
|
5 |
|
0.1% |
|
|
|
4 |
|
|
0.00 |
Impact of the Tax Cuts
and Jobs Act |
|
— |
|
0.0% |
|
|
|
(1,321) |
|
|
(0.08) |
Loss on the
extinguishment of debt |
|
— |
|
0.0% |
|
|
|
250 |
|
|
0.02 |
Derivative fair value
gain |
|
— |
|
0.0% |
|
|
|
(247) |
|
|
(0.02) |
Amortization of debt
discounts and financing costs |
|
— |
|
0.0% |
|
|
|
217 |
|
|
0.01 |
Non-GAAP measure |
$26,870 |
|
22.0% |
|
|
$20,199 |
|
|
$1.26 |
Year Ended July
31, 2018 |
KMG Chemicals, Inc. |
Dollars in thousands,
except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP measure |
$88,125 |
|
18.9% |
|
|
$64,841 |
|
|
$4.29 |
Amortization of
Flowchem intangible assets |
|
12,575 |
|
2.7% |
|
|
|
9,181 |
|
|
0.61 |
Acquisition &
integration expenses |
|
1,843 |
|
0.4% |
|
|
|
1,345 |
|
|
0.09 |
Restructuring &
realignment charges |
|
74 |
|
0.0% |
|
|
|
54 |
|
|
0.01 |
Impact of the Tax Cuts
and Jobs Act |
|
— |
|
0.0% |
|
|
|
(12,326) |
|
|
(0.82) |
Loss on the
extinguishment of debt |
|
— |
|
0.0% |
|
|
|
4,899 |
|
|
0.32 |
Derivative fair value
gain |
|
— |
|
0.0% |
|
|
|
(4,070) |
|
|
(0.27) |
Amortization of debt
discounts and financing costs |
|
— |
|
0.0% |
|
|
|
1,037 |
|
|
0.07 |
Debt repricing
transaction costs |
|
— |
|
0.0% |
|
|
|
443 |
|
|
0.03 |
Non-GAAP measure |
$102,617 |
|
22.0% |
|
|
$65,404 |
|
|
$4.33 |
Fourth Quarter
Fiscal 2017 |
KMG Chemicals, Inc. |
Dollars in thousands,
except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP measure |
$ 10,245 |
|
|
10.6% |
|
|
$5,338 |
|
|
$0.43 |
Acquisition &
integration expenses |
|
405 |
|
|
0.4% |
|
|
|
263 |
|
|
0.02 |
Loss on the
extinguishment of debt |
|
353 |
|
|
0.4% |
|
|
|
230 |
|
|
0.02 |
Restructuring &
realignment charges |
|
(50) |
|
|
(0.0%) |
|
|
|
(32) |
|
|
0.00 |
Corporate relocation
expense |
|
1 |
|
|
0.0% |
|
|
|
1 |
|
|
0.00 |
Effect of purchase
price accounting on acquired inventories valuation* |
|
3,674 |
|
|
3.8% |
|
|
|
2,735 |
|
|
0.22 |
Non-GAAP measure |
$14,628 |
|
|
15.2% |
|
|
$8,535 |
|
|
$0.69 |
|
* Higher
costs of goods sold for our performance materials segment related
to the fair value adjustment in purchase accounting for acquired
inventories. Only 73% of the purchase price adjustment is
deductible for income taxes and has therefore been included in the
calculation of the tax-effect of the items impacting pre-tax
income. |
|
KMG Chemicals, Inc. |
Year Ended July
31, 2017 |
|
Dollars in thousands,
except EPS |
|
|
Operating |
|
Net |
|
Diluted Earnings |
Income |
|
Margin |
|
Income |
|
Per Share |
GAAP measure |
$37,333 |
|
11.2% |
|
|
$23,633 |
|
$1.92 |
Acquisition &
integration expenses |
|
1,550 |
|
0.5% |
|
|
|
1,008 |
|
0.08 |
Loss on the
extinguishment of debt |
|
353 |
|
0.1% |
|
|
|
229 |
|
0.02 |
Restructuring &
realignment charges |
|
20 |
|
0.0% |
|
|
|
13 |
|
0.01 |
Corporate relocation
expense |
|
370 |
|
0.1% |
|
|
|
241 |
|
0.02 |
Effect of purchase
price accounting on acquired inventories valuation* |
|
3,674 |
|
1.1% |
|
|
|
2,735 |
|
0.22 |
Non-GAAP measure |
$43,300 |
|
13.0% |
|
|
$27,859 |
|
$2.27 |
|
* Higher
costs of goods sold for our performance materials segment related
to the fair value adjustment in purchase accounting for acquired
inventories. Only 73% of the purchase price adjustment is
deductible for income taxes and has therefore been included in the
calculation of the tax-effect of the items impacting pre-tax
income. |
|
|
KMG Investor Relations
Eric Glover, 817-761-6006
eglover@kmgchemicals.com
Kerr Mcgee (NYSE:KMG)
過去 株価チャート
から 12 2024 まで 1 2025
Kerr Mcgee (NYSE:KMG)
過去 株価チャート
から 1 2024 まで 1 2025